Clinical Trial Update: ERAP1,2 in Recalcitrant Warts

View source ↗

Summary

A clinical trial evaluating ERAP1 and ERAP2 for recalcitrant warts has completed, sponsored by Benha University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Warts

Drugs mentioned

• ERAP1/ERAP2 inhibitors (ERAP1/ERAP2)

Snippet

Sponsor: Benha University | Conditions: Warts | Status: COMPLETED